Abstract
(-)-9-[4-Hydroxy-2-(hydroxymethyl)butyl]guanine was evaluated for its efficacy in African green monkeys infected with simian varicella virus. Treatment by intramuscular injection was initiated 48 h after virus inoculation and was continued for 10 days; the treatment showed therapeutic effects on rash and viremia at dosages down to 1 mg/kg of body weight per day.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abele G., Eriksson B., Harmenberg J., Wahren B. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate. Antimicrob Agents Chemother. 1988 Aug;32(8):1137–1142. doi: 10.1128/aac.32.8.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abele G., Karlström A., Harmenberg J., Shigeta S., Larsson A., Lindborg B., Wahren B. Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother. 1987 Jan;31(1):76–80. doi: 10.1128/aac.31.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lake-Bakaar D. M., Abele G., Lindborg B., Soike K. F., Datema R. Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug. Antimicrob Agents Chemother. 1988 Dec;32(12):1807–1812. doi: 10.1128/aac.32.12.1807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lake-Bakaar D. M., Lindborg B., Datema R. Improvement of the absorption of oral (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, an anti-varicella-zoster virus drug, in rats and monkeys. Antimicrob Agents Chemother. 1989 Jan;33(1):110–112. doi: 10.1128/aac.33.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soike K. F., Gerone P. J. Acyclovir in the treatment of simian varicella virus infection of the African green monkey. Am J Med. 1982 Jul 20;73(1A):112–117. doi: 10.1016/0002-9343(82)90075-4. [DOI] [PubMed] [Google Scholar]
- Soike K. F., Huang J. L., Zhang J. Y., Bohm R., Hitchcock M. J., Martin J. C. Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral Res. 1991 Jul;16(1):17–28. doi: 10.1016/0166-3542(91)90055-v. [DOI] [PubMed] [Google Scholar]
- Vere Hodge R. A., Sutton D., Boyd M. R., Harnden M. R., Jarvest R. L. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]. Antimicrob Agents Chemother. 1989 Oct;33(10):1765–1773. doi: 10.1128/aac.33.10.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Miranda P., Krasny H. C., Page D. A., Elion G. B. The disposition of acyclovir in different species. J Pharmacol Exp Ther. 1981 Nov;219(2):309–315. [PubMed] [Google Scholar]